RECURRENT CHILDHOOD EPENDYMOMA
Clinical trials for RECURRENT CHILDHOOD EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CHILDHOOD EPENDYMOMA trials appear
Sign up with your email to follow new studies for RECURRENT CHILDHOOD EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with resistant cancers: targeted drug shows promise in early trial
Disease control OngoingThis study tested a drug called erdafitinib in children and young adults (ages 1 to 21) whose cancers had spread, returned, or stopped responding to treatment. The drug targets tumors with specific changes in FGFR genes. The main goal was to see if the drug could shrink or stop t…
Matched conditions: RECURRENT CHILDHOOD EPENDYMOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kids with aggressive brain cancers: early trial tests Immune-Boosting drug
Disease control OngoingThis early-stage trial is testing the safety and early effectiveness of a drug called pembrolizumab in children and young adults whose aggressive brain tumors have come back or stopped responding to standard treatments. The drug is a type of immunotherapy designed to help the bod…
Matched conditions: RECURRENT CHILDHOOD EPENDYMOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 13, 2026 20:17 UTC